|
| |
IMS HealthWhether you are freshly out of an undergraduate or have an MBA under your belt, our firm offers an invigorating atmosphere and a challenging career option that can help you realize your full professional potential. With our driverse mox of top Pharma and Biotech clients,you will gain exposure to soving the most pressing issues facing pharmaceutical executives and as a result help shape a Heather future for us all
| Contact Details: |
| 80 Board Street,35th Floor |
| New York City |
| New York |
| 10004 |
| United States of America |
| Tel: | 1 646 274 1800 |
| Fax: | |
| Email: | infopandr@imshealth.com |
| WWW: | www.cambriabio.com/
|
|
Loading...
|
Recent Publications by IMS Health: |  |
Self-monitoring of blood glucose (SMBG) in patients with type 2 diabetes on oral anti-diabetes drugs: cost-effectiveness in France, Germany, Italy, and Spain.
Abstract Objective: Stakeholders in Europe remain interested in... | 19th November, 2009
| IMS Health, Inc. Falls Church, VA, USA.
| Curr Med Res Opin. 2009 Nov 18.
DOI Direct Link |
Self-monitoring of blood glucose (SMBG) for type 2 diabetes patients treated with oral anti-diabetes drugs and with a recent history of monitoring: cost-effectiveness in the US.
Abstract Objective: Stakeholders in the US and elsewhere are interested in... | 19th November, 2009
| IMS Health Inc., Falls Church, VA, USA.
| Curr Med Res Opin. 2009 Nov 18.
DOI Direct Link |
Retrospective study of total healthcare costs associated with chronic nonvalvular atrial fibrillation and the occurrence of a first transient ischemic attack, stroke or major bleed.
OBJECTIVE: To determine the direct healthcare costs associated with the... | 18th November, 2009
| IMS Health, Plymouth Meeting, PA, USA.
| Curr Med Res Opin. 2009 Dec;25(12):2853-64.
DOI Direct Link |
Patient-reported reasons for discontinuing overactive bladder medication.
OBJECTIVE To evaluate patient-reported reasons for discontinuing... | 17th November, 2009
| IMS Health, Falls Church, VA, USA.
| BJU Int. 2009 Nov 12.
DOI Direct Link |
Photodynamic therapy using methyl aminolevulinate in the management of primary superficial basal cell carcinoma: clinical and health economic outcomes.
BACKGROUND: Basal cell carcinoma (BCC) is the most common form of skin... | 10th November, 2009
| Health Economics and Outcomes Research, IMS Health, Brussels, Belgium.
| J Drugs Dermatol. 2009 Nov;8(11):992-6.
|
→View more IMS Health research publications. |
Press Releases on IMS Health:
|
 |
| Par Pharmaceutical Receives Final Approval to Market Generic Ultram(R) ER |
16th November, 2009 |
Par Pharmaceutical Companies, Inc. |
WOODCLIFF LAKE, N.J., Nov. 16 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE: PRX) today announced that it has received final approval from the U.S. Food and Drug Administration
|
| Mylan Receives FDA Approval for Generic Version of Prevacid(R) Through its Subsidiary Matrix Laboratories |
10th November, 2009 |
Mylan Inc. |
PITTSBURGH, Nov. 10 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL) today announced that its privately held Indian subsidiary, Matrix Laboratories Limited, has received final approval from the U.S.
|
| Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2009 |
9th November, 2009 |
Warner Chilcott plc |
ARDEE, Ireland, Nov. 9 /PRNewswire-FirstCall/ -- Warner Chilcott plc (Nasdaq: WCRX) today announced its results for the quarter ended September 30, 2009. Revenue in the quarter ended September 30,
|
| Par Pharmaceutical Reports EPS of $0.76 for Third Quarter 2009 |
6th November, 2009 |
Par Pharmaceutical Companies |
-- Metoprolol: For the quarter ended October 3, 2009, net sales of
metoprolol succinate were $161.1 million, a decrease of 47% from the
second quarter 2009. The decrease was
|
| Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) |
6th November, 2009 |
|
PARIS, November 6 /PRNewswire/ -- Novexel, a speciality pharmaceutical company focused on the
discovery and development of novel antibiotics designed to overcome the
significant global problem of
|
 Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 680 times since April 2007, the link to the organisation's website has been followed 84 times Recent Search Terms used to find this page: imshealth adhepta | Economic outcomes associated with microvascular complications of type 2 diabetes mellitus results from a US claims data analysis. | opportunities and threats facing IMS health | IMS Health Database | ims health health report global 2009 pdf | ims health 2009 trend report pdf | IMS health database | 646-274-1800 | IMS Health database Top pharmaceutical companies 2009 | IMS health switzerland career | . Search for more companies in New York City Search for more companies in New York This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for IMS Health |
